Search by Drug Name or NDC

NDC 65162-0414-50 Clopidogrel 75 mg/1 Details

Clopidogrel 75 mg/1

Clopidogrel is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is CLOPIDOGREL BISULFATE.

MedlinePlus Drug Summary

Clopidogrel is used alone or with aspirin to prevent serious or life-threatening problems with the heart and blood vessels in people who have had a stroke, heart attack, or severe chest pain. This includes people who have percutaneous coronary intervention (PCI; angioplasty; a type of heart surgery) that may involve inserting coronary stents (metal tubes surgically placed in clogged blood vessels to improve blood flow) or who have coronary artery bypass grafting (CABG; a type of heart surgery). Clopidogrel is also used to prevent serious or life-threatening problems with the heart and blood vessels in people who have peripheral arterial disease (poor circulation in the blood vessels that supply blood to the legs). Clopidogrel is in a class of medications called antiplatelet medications. It works by preventing platelets (a type of blood cell) from collecting and forming clots that may cause a heart attack or stroke.

Related Packages: 65162-0414-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Clopidogrel

Product Information

NDC	65162-0414
Product ID	65162-414_26d6bbc2-fc1e-45c3-953d-dbecde03220b
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Clopidogrel
Proprietary Name Suffix	n/a
Non-Proprietary Name	Clopidogrel
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	75
Active Ingredient Units	mg/1
Substance Name	CLOPIDOGREL BISULFATE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA203751
Listing Certified Through	2024-12-31

Package

NDC 65162-0414-50 (65162041450)

Pricing Information	N/A
NDC Package Code	65162-414-50
Billing NDC	65162041450
Package	500 TABLET in 1 BOTTLE (65162-414-50)
Marketing Start Date	2013-09-30
NDC Exclude Flag	N